Eligibility criteria in heart failure randomized controlled trials: a gap between evidence and clinical practice-Reference-Cited by-同舟云学术

Eligibility criteria in heart failure randomized controlled trials: a gap between evidence and clinical practice

Published:2008-08-09 Issue:2 Volume:4 Page:117-122
ISSN:1828-0447
Container-title:Internal and Emergency Medicine
language:en
Short-container-title:Intern Emerg Med

Author:

Costantino Giorgio,Rusconi Anna Maria,Duca Pier Giorgio,Guzzetti Stefano,Bossi Ilaria,Del Medico Marta,Pisano Giuseppina,Bulgheroni Mara,Solbiati Monica,Furlan Raffaello,Montano Nicola

Publisher

Springer Science and Business Media LLC

Subject

Emergency Medicine,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s11739-008-0180-9.pdf

Reference25 articles.

1. The SOLVD Investigators ((1991)) Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 325:293–302

2. Packer M, Bristow MR, Cohn JN et al (1996) The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334:1349–1355

3. Pitt B, Zannad F, Remme WJ et al (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 341:709–717

4. Cohn JN, Rognoni G, for the Valsartan heart failure trial investigators (2001) A randomized trial of the angiotensin-receptor blocker Valsartan in chronic heart failure. N Engl J Med 345:1667–1675

5. Ho KK, Anderson KM, Kannel WB et al (1993) Survival after the onset of congestive heart failure in Framingham heart study subjects. Circulation 88:107–115

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel approach to assessing disparity in representativeness of clinical trial participants within a large midwestern healthcare system;Contemporary Clinical Trials Communications;2024-04

2. A Novel Approach to Assessing Disparity in Representativeness of Clinical Trial Participants within a Large Midwestern Healthcare System;2023

3. Eligible-and-enrolled vs. eligible-but-not-enrolled patients with chronic ischaemic heart failure in randomized clinical trials of myocardial regeneration;Advances in Interventional Cardiology;2022

4. Clinical comparison between trial participants and potentially eligible patients using electronic health record data: A generalizability assessment method;Journal of Biomedical Informatics;2021-07

5. Prognostic association of medication trajectories with 3-year mortality in heart failure and preserved ejection fraction: findings from the EPICAL2 cohort study;European Journal of Clinical Pharmacology;2021-05-10